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sound. The patient’s aneurysm grew suddenly and rapidly to its
large size just prior to its rupture. The growth of the aneurysm
was generally paralleled by an increase in size of the patient’s liver
metastases from his pancreatic carcinoma. While it was true that
the patient was a worse candidate for surgical intervention at the
time of aneurysm rupture than at his initial surgical exploration
13 months earlier, I agree with the decision of his original sur-
geons (from another institution) to not repair his aneurysm then
since his life expectancy was so limited by his metastatic tumor.
This patient was a well-informed general and vascular surgeon
who knew the natural history of both his tumor and his aneurysm.
At all times during his course he was aware of his CT scan findings
and the enlargement of both his tumor and his aneurysm. All the
related issues were fully discussed with the patient and his family,
and it was his choice not to treat his aneurysm despite its enlarge-
ment. When the aneurysm ruptured, he was aware of the diagno-
sis and prognosis. He elected to have the aneurysm repaired at that
time. Although he survived the operation and had a feeling of
well-being for a short time, his pancreatic tumor resulted in his
demise. Having taken care of this patient during his terminal ill-
ness and having witnessed the distress of the patient and his fam-
ily, no one could be more aware than I of the importance of the
issues raised by the writers of the letter.
Frank J. Veith, MD
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Regarding “Crushed stents in benign left
brachiocephalic vein stenoses”
To the Editors: 
The article by Drs Hammer, Becker, Gofette, and Mathurin1
is very important. It confirms the experience of surgeons working
with venous obstructions in the thoracic outlet who know that
stents in those positions commonly lead to complete obstruction.
The reason is twofold: (1) the previous intimal injury that those
veins have been subjected to by chronic catheters and, most
important, (2) the mechanical extrinsic compression at the tho-
racic outlet. This compression is clearly shown by the authors. In
the typical uninjured person, the vein is quite pliable, usually flat,
but changes its shape when the soft tissues relax with any type of
arm and neck motion. However, once the vein becomes rigid
with the stents, the result is predictable. The thoracic inlet is nar-
row, and the venous conduit is compressed between the aorta,
innominate arteries, subclavian arteries, and the sternum—as the
authors show in the computerized scan. Since most of these stents
are relatively long (5-8 cm or even longer), the compression
begins at the level of the first rib. For patients on dialysis who
have had fistulas in the arm and previous central dialysis catheters,
the venous return becomes critical if that vein obstructs.2,3
Therefore, my advice (like the authors’) continues to be this: if
stenosis is evident in the innominate-subclavian vein segment, the
surgeon must first decompress the channel through which this
vein runs. Doing so involves removing the first rib, the subclavius
tendon, and the anterior scalene tendon, using an anterior
approach.4 Once decompression is accomplished, then it will be
much safer to implant the stents, because there will be no struc-
tures behind to compress the venous channel that lies loosely over
the pleura. At the University of Minnesota, we have up to 13-year
follow-up data on stents placed in the innominate vein position
following surgical decompression: they have good patency. In
medical centers where this condition is treated, the subclavian
vein is most commonly the main target of stent placement.
Unfortunately, patients who have such stents placed without sur-
gical decompression of the thoracic outlet do develop obstruction
of the stented segment. This complication has been reported sev-
eral times,5,6 but these reports are apparently being ignored, so
the same mistake is being repeated.
One point the authors failed to make is that balloon angio-
plasty alone of a fibrotic or stenotic vein in the thoracic outlet
never works. The vein invariably collapses or fibroses again, so
physicians resort immediately to use of stents. This is the wrong
step, because the stent will also collapse and will invariably
obstruct the vein—as the authors have shown in the two cases
they reported here—if the thoracic outlet is not decompressed
first.5,6
I would like to emphasize, even more strongly than the
authors did, that everybody working in this area must be fully
aware that placing a stent in those veins is a no-return maneuver.
Once it is done, if the vein subsequently obstructs, the next step
is to remove the entire obstructed segment of vein and implant a
bypass graft. Since no prosthetic pliable grafts are available that
work in the venous system, we have resorted to the use of small
descending thoracic aortic homografts,7,8 which have shown
good patency after 8 years.9 However, this solution is not yet
widely available: our current use of homografts is still part of a
preliminary clinical study.
J. Ernesto Molina, MD
Cardiovascular and Thoracic Surgery
University of Minnesota Medical School
Minneapolis, Minn
REFERENCES
1. Hammer F, Becker D, Gofette P, et al. Crushed stents in benign left
brachiocephalic vein stenoses. J Vasc Surg 2000;32:392-6.
2. Lumsden AB, MacDonald MJ, Isiklar H, et al. Central venous steno-
sis in the hemodialysis patient: incidence and efficacy of endovascular
treatment. Cardiovasc Surg 1997;5:504-9.
3. Beathard G. Percutaneous transvenous angioplasty in the treatment of
vascular access stenosis. Kidney Int 1992;42:1390-7.
4. Molina JE. Surgery for effort thrombosis of the subclavian vein. J
Cardiovasc Surg 1992;103:341-6.
5. Meier GH, Pollak JS, Rosenblatt M, et al. Initial experience with
venous stents in exertional axillary-subclavian vein thrombosis. J Vasc
Surg 1996;24:974-83.
6. Bjarnason H, Hunter DW, Crain MR, et al. Collapse of a Palmaz stent
in the subclavian vein. AJR Am J Roentgenol 1993;160:1123-4.
7. Molina JE. A new surgical approach to the innominate and subclavian
vein. J Vasc Surg 1998;27:576-81.
8. Molina JE. Approach to the confluence of the subclavian and internal
jugular veins without claviculectomy. Semin Vasc Surg 2000;13:10-9.
9. Molina JE. Use of cryopreserved small aortic homografts for large
vein replacement. Vasc Surg 1999;33:545-55.
24/41/113490
doi:10.1067/mva.2001.113490
Reply
The comments of Pr. Molina are pertinent. We indeed con-
sider that stent placement in the subclavian vein or axillary vein
should be banished because of external constraints appearing dur-
ing arm and neck movements, rapidly leading to stent compres-
sion and finally stent fracture or dislocation. This has been
described in previous case reports. Therefore, as mentioned by Pr
Molina, the only viable solution in case of stent placement in this
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